30 November 2021

[Coating] – Pre-coating nanoparticles to better deal with protein coronas.

Home > News > [Coating] – Pre-coating nanoparticles to better deal with protein coronas.
Flèche contenu
Coating - Codex International

A major goal in nanomedicine is to make nanoparticles with the capability of in vivo targeting for both imaging and delivery of therapeutic biomolecules in the human body. One strategy to obtain a high targeting yield is to functionalize the surface of nanoparticles with targeting ligands – like antibodies or aptamers – that enhance the binding of nanoparticles to receptors on the target cells and facilitate nanoparticle uptake by receptor-mediated endocytosis.

revious reports have shown that when nanoparticles enter the blood stream, the proteins that adsorb onto nanoparticles when they enter the body form a protein corona that hinders interactions between the targeting ligands on the nanoparticles and their binding partners on the cells’ surface ; also see these papers in Chemical Communications: “Protein corona significantly reduces active targeting yield” and Nature Nanotechnology: “Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.”).

To address this issue, scientists have developed a strategy that enables directing the formation of protein coronas on nanoparticles that are enriched in plasma proteins with natural targeting capabilities. This involves pre-coating nanoparticles with selected proteins prior to their exposure to the desired biological environment.

“One strategy that has been proposed to address this challenge is to exploit the protein corona itself for targeted nanoparticle delivery,” Morteza Mahmoudi, an assistant professor at Tehran University of Medical Sciences, who heads the Laboratory of Nano-Bio Interactions, and a Visiting Professor at Stanford University’s School of Medicine. “We were motivated to investigate the feasibility and limitations of this emerging strategy because few studies have probed whether plasma proteins with natural targeting capabilities could be selectively recruited to the nanoparticles’ surfaces and used to direct nanoparticle uptake by desired cell types.”

The team’s findings show that the surface of a nanoparticle can be engineered to promote the formation of a hard protein corona that is enriched with desired proteins, but a lack of control over the conformations and accessibility of the recruited proteins is currently a limitation of this approach.

These results have been published in the October 9, 2015 online edition of Biomaterials(“Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake”).

The team, led by Mary L. Kraft, an associate professor at the University of Illinois at Urbana-Champaign, and Mahmoudi, demonstrated that by pre-coating nanoparticles with proteins that promote the adsorption of desired plasma proteins, they can direct the formation of a protein corona on the surface of a nanoparticle that is enriched in plasma proteins with natural targeting capabilities.

“However, the corona proteins with targeting capabilities did not significantly promote nanoparticle uptake by the desired cells because they were screened by other proteins in the hard corona,” says Kraft. “Therefore, to form a functional corona with targeting capabilities, the desired plasma proteins must not only be enriched in the corona, but they must also be positioned such that their binding motifs are accessible to the receptors on the surfaces of the target cells.”

These results indicate that strategies for producing protein coronas with targeting capabilities on nanoparticles must not only promote the recruitment of the desired plasma proteins to the nanoparticles? surfaces, but also control their orientations so that they can access binding partners on the target cells.

With further development, nanoparticles functionalized with protein coronas that have targeting capabilities might be used for diagnostic applications – by sensitive targeted imaging – and therapeutics by selectively transporting cytotoxic, i.e., anticancer, drugs to the diseased cells in the body, which would reduce the undesired side effects of these therapies.

Discover Also
[MEMS] – Sensing the environment as with human senses 23 February 2020

What had long been considered as a vision of the future is now a reality – devices can detect their surroundings as if they were human senses and interact with them. Sensors close the gap to the digital world. Combined with appropriate software, smart devices and robots, for example, can see, hear, smell or feel and above all “intuitively understand” their environment, thereby simplifying our lives. The decisive factor here is the interpretation and linking of information from different sensors.

Read more
[Nanotechnology] – Novel molecular imaging technique casts complex coordination molecules in a new light. 20 September 2021

High-angle annular dark-field scanning transmission electron microscopy can be used to determine complex conformational structures of both crystalline and amorphous polynuclear non-planar coordination molecules, …

Read more